These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 17206948

  • 21. Comparison of the effects of proton pump inhibitors on human plasma adrenocorticotropic hormone and cortisol levels under the starved condition.
    Katagiri F, Inoue S, Sato Y, Itoh H, Takeyama M.
    Biomed Pharmacother; 2006 Apr; 60(3):109-12. PubMed ID: 16524691
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers.
    Tomilo DL, Smith PF, Ogundele AB, Difrancesco R, Berenson CS, Eberhardt E, Bednarczyk E, Morse GD.
    Pharmacotherapy; 2006 Mar; 26(3):341-6. PubMed ID: 16503713
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
    Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ.
    Am J Med; 2004 Jun 01; 116(11):740-8. PubMed ID: 15144910
    [Abstract] [Full Text] [Related]

  • 29. Proton pump inhibitor therapy: preliminary results of a therapeutic interchange program.
    Amidon PB, Jankovich R, Stoukides CA, Kaul AF.
    Am J Manag Care; 2000 May 01; 6(5):593-601. PubMed ID: 10977467
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Microscopic colitis associated with omeprazole and esomeprazole exposure.
    Wilcox GM, Mattia AR.
    J Clin Gastroenterol; 2009 Jul 01; 43(6):551-3. PubMed ID: 19142168
    [Abstract] [Full Text] [Related]

  • 34. Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis -- a mixed treatment comparison of randomized controlled trials.
    Edwards SJ, Lind T, Lundell L, DAS R.
    Aliment Pharmacol Ther; 2009 Sep 15; 30(6):547-56. PubMed ID: 19558609
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Delivery of omeprazole and lansoprazole granules through a nasogastric tube in vitro.
    Dunn A, White CM, Reddy P, Quercia RA, Chow MS.
    Am J Health Syst Pharm; 1999 Nov 15; 56(22):2327-30. PubMed ID: 10582827
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of lansoprazole in hemodialysis patients.
    Karol MD, Machinist JM, Cavanaugh JM.
    J Clin Pharmacol; 1995 Aug 15; 35(8):815-20. PubMed ID: 8522639
    [Abstract] [Full Text] [Related]

  • 39. Lansoprazole oro-dispersible tablet : pharmacokinetics and therapeutic use in acid-related disorders.
    Baldi F.
    Drugs; 2005 Aug 15; 65(10):1419-26. PubMed ID: 15977971
    [Abstract] [Full Text] [Related]

  • 40. Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients.
    Olsen KM, Devlin JW.
    Aliment Pharmacol Ther; 2008 Aug 01; 28(3):326-33. PubMed ID: 19086331
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.